Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

UK Hepatitis Test Solution Diagnosis Market

ID: MRFR/HC/48967-HCR
200 Pages
Vikita Thakur
Last Updated: May 13, 2026
UK Hepatitis Test Solution Diagnosis Market Research Report By Test Type (Serological Tests, Nucleic Acid Tests, Direct Antigen Tests, Rapid Diagnostic Tests), By Technology (ELISA, PCR, Gene Sequencing, Immunoassays), By End User (Hospitals, Diagnostic Laboratories, Research Institutions, Home Care) and By Sample Type (Blood Samples, Urine Samples, Saliva Samples) - Growth & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Food, Beverages & Nutrition, BY Type (USD Million) | |
      1. 4.1.1 Serological Tests | |
      2. 4.1.2 Nucleic Acid Tests | |
      3. 4.1.3 Direct Antigen Tests | |
      4. 4.1.4 Rapid Diagnostic Tests |
    2. 4.2 Food, Beverages & Nutrition, BY Technology (USD Million) | |
      1. 4.2.1 ELISA | |
      2. 4.2.2 PCR | |
      3. 4.2.3 Gene Sequencing | |
      4. 4.2.4 Immunoassays |
    3. 4.3 Food, Beverages & Nutrition, BY End User (USD Million) | |
      1. 4.3.1 Hospitals | |
      2. 4.3.2 Diagnostic Laboratories | |
      3. 4.3.3 Research Institutions | |
      4. 4.3.4 Home Care |
    4. 4.4 Food, Beverages & Nutrition, BY Sample Type (USD Million) | |
      1. 4.4.1 Blood Samples | |
      2. 4.4.2 Urine Samples | |
      3. 4.4.3 Saliva Samples 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Food, Beverages & Nutrition | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Food, Beverages & Nutrition | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Abbott Laboratories (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Roche Diagnostics (CH) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Siemens Healthineers (DE) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Thermo Fisher Scientific (US) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Bio-Rad Laboratories (US) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Ortho Clinical Diagnostics (US) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Hologic (US) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Cepheid (US) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 UK MARKET ANALYSIS BY TYPE |
    6. 6.3 UK MARKET ANALYSIS BY TECHNOLOGY |
    7. 6.4 UK MARKET ANALYSIS BY END USER |
    8. 6.5 UK MARKET ANALYSIS BY SAMPLE TYPE |
    9. 6.6 KEY BUYING CRITERIA OF FOOD, BEVERAGES & NUTRITION |
    10. 6.7 RESEARCH PROCESS OF MRFR |
    11. 6.8 DRO ANALYSIS OF FOOD, BEVERAGES & NUTRITION |
    12. 6.9 DRIVERS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION |
    13. 6.10 RESTRAINTS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION |
    14. 6.11 SUPPLY / VALUE CHAIN: FOOD, BEVERAGES & NUTRITION |
    15. 6.12 FOOD, BEVERAGES & NUTRITION, BY TYPE, 2024 (% SHARE) |
    16. 6.13 FOOD, BEVERAGES & NUTRITION, BY TYPE, 2024 TO 2035 (USD Million) |
    17. 6.14 FOOD, BEVERAGES & NUTRITION, BY TECHNOLOGY, 2024 (% SHARE) |
    18. 6.15 FOOD, BEVERAGES & NUTRITION, BY TECHNOLOGY, 2024 TO 2035 (USD Million) |
    19. 6.16 FOOD, BEVERAGES & NUTRITION, BY END USER, 2024 (% SHARE) |
    20. 6.17 FOOD, BEVERAGES & NUTRITION, BY END USER, 2024 TO 2035 (USD Million) |
    21. 6.18 FOOD, BEVERAGES & NUTRITION, BY SAMPLE TYPE, 2024 (% SHARE) |
    22. 6.19 FOOD, BEVERAGES & NUTRITION, BY SAMPLE TYPE, 2024 TO 2035 (USD Million) |
    23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    24. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    25. 7.2 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million) | |
      2. 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
      3. 7.2.3 BY END USER, 2025-2035 (USD Million) | |
      4. 7.2.4 BY SAMPLE TYPE, 2025-2035 (USD Million) |
    26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.3.1 |
    27. 7.4 ACQUISITION/PARTNERSHIP | |

UK Food, Beverages & Nutrition Market Segmentation

Food, Beverages & Nutrition By Type (USD Million, 2025-2035)

  • Serological Tests
  • Nucleic Acid Tests
  • Direct Antigen Tests
  • Rapid Diagnostic Tests

Food, Beverages & Nutrition By Technology (USD Million, 2025-2035)

  • ELISA
  • PCR
  • Gene Sequencing
  • Immunoassays

Food, Beverages & Nutrition By End User (USD Million, 2025-2035)

  • Hospitals
  • Diagnostic Laboratories
  • Research Institutions
  • Home Care

Food, Beverages & Nutrition By Sample Type (USD Million, 2025-2035)

  • Blood Samples
  • Urine Samples
  • Saliva Samples